Contact Us

EKSO BIONICS receives FDA clearance for Ekso GT™

First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7 in accordance with device’s labeling.*

United States


General Information

510-984-1761

Customer Experience

customerrelations@eksobionics.com

Industrial

industrial@eksobionics.com

Human Resources

hr@eksobionics.com

Marketing

marketing@eksobionics.com

Europe


Media Inquiries


hdietrich@eksobionics.com

+49 761 557834 30


Customer Relations

Enquiries@eksobionics.com

+49 761 557834 20

UK Customer Relations


+44 20 7060 3568

Cutting-Edge Rehab Technology

Ekso Bionics Inc. recently announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke.

  • News